| 1. | vmt646 | |
| 2. | maurizio84b821h | |
| 3. | bestaleymd4 | |
| 4. | dcscha5 | |
| 5. | glendongilbert |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | maurizio84b821h 03/15/2018 Announces positive top-line results showing successful Phase 3 clinical study of ALXN1210 in complement … |
| 2. | glendongilbert 02/08/2018 Exactly |
| 3. | krh28 04/27/2018 Stifel Nicolaus |
| 4. | maurizio84b821h 02/08/2018 Lol red huh? my luck |
| 5. | bestaleymd4 02/05/2018 Evercore ISI raises to outperform |
| 6. | vmt646 02/08/2018 and out. |
| 7. | vmt646 04/20/2018 Alexion Provides Statement on Superior Court of Justice (STJ) Decision in Brazil Involving Soliris® (Eculizumab) |
| 8. | bestaleymd4 02/08/2018 some things are under ones control |
| 9. | maurizio84b821h 04/26/2018 Announces positive topline results of a Phase 3 study of ALXN1210 |
| 10. | maurizio84b821h 06/11/2018 Alexion Pharma and Complement Pharma |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
Alexion Pharmaceuticals, Inc.
- ALXN
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.